The nature of the inhibitory neurotransmitter responsible for internal anal sphincter (IAS) relaxation in response 'to rectoanal reflex is not known. The objective of the present investigation was to examine the role of VIP in IAS relaxation in response to the rectoanal reflex in intact opossums with the use of VIP antagonists, 14CI-D-Phe',Leu'71 VIP and (N-AcTyr',D-Phe2)-GRF (1-29)-NH2. Intraluminal pressures from the sphincter were monitored using low-compliance, continuously perfused catheters. VIP and the antagonists were administered close-intraarterially. The responses to VIP, rectoanal reflex, sacral nerve stinulation, and local intramural stimulation were examined before and after the VIP antagonists. The present studies in intact animals show: (a) VIP causes a dose-dependent fall in the IAS pressures by a direct action at the IAS smooth muscle; (b) VIP antagonists selectively and significantly antagonized the inhibitory action of VIP; and (c) VIP antagonists caused significant antagonism of the IAS relaxation caused by rectoanal reflex and the other neural stimuli. The antagonism of the IAS relaxation by the VIP antagonists, depending upon the volume of rectal distension used, ranged from 40% to 62% (P < 0.05). From these results, we conclude that VIP acts as an inhibitory neurotransmitter for IAS relaxation during the rectoanal reflex.
Introduction
It has been previously shown that internal anal sphincter (IAS)1 relaxation is mediated through the release of a noncholinergic, nonadrenergic inhibitory neurotransmitter (1) (2) (3) (4) (5) . Such noncholinergic, nonadrenergic nerves play a significant role in the relaxation of a variety of smooth muscle tissues (6, 1. Abbreviations used in this paper: D50, dose producing 50% of the maximal response; EFS, electrical field stimulation; GRF analogue, (N-Ac-Tyr',D-Phe2)-GRF 7 ). However, the exact nature ofthe inhibitory neurotransmitter responsible for the relaxation of these smooth muscle tissues and IAS relaxation is not known. It has been suggested that vasoactive intestinal polypeptide (VIP) acts as a neurotransmitter in certain systems (8) (9) (10) (11) (12) (13) . Previous in vivo and in vitro studies in the. lower esophageal sphincter (LES) (11, 14) and in vitro studies in the IAS (3) using VIP antiserum have suggested that VIP may play a role in IAS relaxation. However, studies using newly discovered VIP antagonists (15, 16) to examine the participation of VIP as an inhibitory neurotransmitter have not been performed in vivo or in vitro for any smooth muscle including the IAS.
The aim of the present investigation was to examine the possibility of VIP as a noncholinergic, nonadrenergic inhibitory nerotransmitter responsible for the relaxation of the internal anal sphincter in response to the rectoanal reflex (mimicked by rectal balloon distension).
Methods
Animal preparation. Studies were performed on 23 opossums (Didelphis virginiana) of either sex weighing between 1.6 and 2.8 kg with a mean of 2.1 kg. The opossum was chosen as the animal model for a number of reasons. The high pressures in the anal canal in this animal species are primarily due to IAS smooth muscle (17) . The detailed studies of myenteric (18) and submucosal (19) plexuses ofthe gut have been carried out in the opossum. The animals were fasted overnight but allowed free access to water. On the day of the experiment each animal was initially anesthetized with pentobarbital sodium (40 mg/kg intraperitoneally) and then restrained supine on an animal board equipped with a water circulating heat pad (model K-20, GormanRupp Industries Div., Belleville, OH) to'maintain the body temperature at 36°C. Either femoral vein was cannulated to provide central venous access for intravenous (i.v.) administration of different agents. The left femoral artery was cannulated and the catheter advanced 10 cm (just cephalad to the aortic bifurcation) for monitoring the blood pressure and localized intraarterial (i.a.) administration of various agents. The position of the i.a. cannula was confirmed at the end of the experiment. Subsequent anesthesia was provided with a-chloralose (70-200 mg i.v.) as needed.
The animals were intubated with a cuffed endotracheal tube (3.0 mm i.d.; 4.3 mm o.d.), and placed on an artificial ventilator (model 661, Harvard Apparatus Co., Millis, MA) at 20 strokes/min. The tidal volume was determined from the Harvard Apparatus ventilation nomogram based on body weight.
The animals were then turned to a prone position. A middorsal incision was made over the pelvisacral region, and the lateral paraspinous muscles were dissected and retracted to expose the sacroiliac joint and sacrum. As described previously (2), the overhanging portion of the pars lateralis and the sacroiliac joint were resected to expose the sacral nerve roots as they emerged from the sacral foramina. Bipolar, silver-silver chloride hook stimulating electrodes were placed in contact with the fourth sacral nerve root to provide sacral nerve stimulation. Bipolar stainless steel needle electrodes (2 mm apart) were in-serted into the muscularis of the distal anal canal, 1 I cm from the anal verge, to provide local intramural stimulation. A balloon constructed as part of the catheter assembly was placed in the rectum as described below. Inflation of the balloon was intended to produce rectal distension. Pancuronium bromide (Organon Inc., W. Orange, NJ) 1 mg/kg i.v. was administered to eliminate the electromyographic activity of the external anal sphincter (17) .
Intraluminal pressure measurements. A specially designed, sixchannel manometry catheter assembly continuously perfused with bubble-free water through a low compliance, pneumohydraulic valve system was used to record internal anal sphincter pressures. The catheter assembly consisted of six polyvinyl tubes (i.d. 0.7 mm, o.d. 1.3 mm; Insultab, Woburn, MA) arranged around a central polyvinyl tube (i.d. 1.6 mm, o.d. 2.4 mm) to which an inflatable balloon constructed from a finger cot was attached. The assembly provided a linear array of six side-hole openings situated at 0.6-cm intervals with an inflatable balloon attached 2 cm beyond the distal port. The total outside diameter ofthe assembly was 4.7 mm. The catheter was positioned so that the pressures from the distal rectum and the entire length of the anal canal could be recorded simultaneously. A pull-through was performed until the highest pressure zone of the IAS was identified. The rectal balloon could be inflated with varying volumes of air without disturbing the position of the catheter assembly. For the sake of uniformity, resting sphincter pressures from the top of the rhythmic fluctuations were recorded in the zone that gave the highest pressures. Pressures were recorded on a Beckman Dynograph recorder (model R71 1, Beckman Instruments Inc., Schiller Park, IL) using Statham transducers. The pressure dynamics of the perfused catheters were such that abrupt occlusion of the catheter tip produced a pressure rise of 200 mmHg in 0.1 s. The baselines were set at atmospheric pressure. Details of the catheter assembly and the procedure for recording pressure have been described before (17) .
Stimulus and drug administration. Baseline responses to isoproterenol hydrochloride (Winthrop Laboratories, New York; mol wt 211.24) 4.8-9.5 X 10-9 mol/kg (1-2 ug/kg) administered i.a. were obtained. Control responses of the fall in internal anal sphincter pressures (IASP) by sacral nerve stimulation from 0.5 to 20 Hz (5 mA; 0.5-ms pulse duration; 2-s train) and local intramural stimulation with 20 and 40 Hz (5 mA; 0.5-ms pulse duration; 2-s train) were obtained using a stimulator (model SI lA, Grass Instrument Co., Quincy, MA). Inhibitory responses to rectal balloon distension on IAS were obtained by inflating the rectal balloon with volumes of 2-15 ml of air for 8 s.
Dose-response curves were obtained after the i.a. administration of vasoactive intestinal polypeptide (VIP) (VIP porcine sequence; Sigma Chemical Co., St. Louis, MO; mol wt 3,326) in doses ranging from 1.1 X 10-'2 to 7.2 x 10-9 mol/kg.
The influence of i.a. administration of the neurotoxin tetrodotoxin (TTX) (Calbiochem-Behring Corp., San Diego, CA; mol wt 319.28) on the VIP dose-response curve was then examined. The initial dose was 1.6 x 10-8 mol/kg (5Mug/kg), and it was then repeated as necessary until the rectoanal reflex response to balloon distension was abolished. In all the experiments where TTX was used, the animals were provided with cardiovascular support with a continuous i.v. infusion of lactated Ringer's at 9 ml/h. The above-mentioned doses of VIP were administered again once the rectal distension-induced IAS relaxation was abolished. The In vitro experiments. In another series of experiments some in vitro studies were performed to examine the possibility of VIP as an inhibitory neurotransmitter in the neurally mediated relaxation of isolated smooth muscle strips of the IAS of the opossum. For these experiments, standard methodology for recording resting tension and its changes in response to electrical field stimulation (EFS) and VIP was employed ( The i.a. catheters, syringes used for injection, and vials containing different peptide solutions and muscle baths were all rinsed with 2.5% bovine serum albumin before use to avoid binding of peptides to polyvinyl tubing, plastic, and glassware. All agents employed in the study were dissolved in physiologic saline. The i.a. or i.v. administration of different volumes of physiological saline produced no significant change either on the resting tone of the IAS or in response to any stimuli.
Data analysis. All results are expressed as mean ±SE of different observations. Changes in IASP and tensions are expressed on percentile as well as absolute bases. The statistical analysis was performed using one-tail t tests or multivariate analysis where appropriate (20) .
Results
Effect of VIP on the resting internal anal sphincter. Intraarterial administration of VIP produced a dose-dependent fall in IASP ( '7] VIP (1.7 X 10-9 to 2.3 x 10-7 mol/kg) on the fall in IASP caused by VIP was examined. It was observed that this VIP analogue was required in the dose of 2.3 X 10-7 mol/kg i.a. to The dose-response curve obtained with VIP in control experiments was shifted significantly to the right after administration ofthe VIP analogue (P < 0.05, n = 8 in four animals at each dose level; Fig. 4 In a separate series of experiments, the dose of [4CI-DPhe6,Leu '7] VIP that antagonized the response of VIP (1.5 X 10-10 mol/kg) was found not to modify the inhibitory effects of isoproterenol (2.9 X 10-10 mol/kg), adenosine (7.9 X l0-7 mol/kg), and PHI (6.0 X 10-1 mol/kg). (Table I) . GRF analogue at a dose that caused significant antagonism ofthe inhibitory effect of VIP on the IAS had no significant effect on the fall in IASP caused by different agonists.
In a separate series of experiments the fall in IASP in response to VIP (1.5 X 10-'°mol/kg), isoproterenol (2.9 X 10-'°°°0 r- Fig. 9 ). This represents an antagonism of 61%.
Influence of GRF VIP. In order to see whether the antagonism of fall in IASP caused by different stimuli with GRF analogue was dose dependent, we compared the influence of two doses, 2.3 X 10-8 and 9.2 X 10-8 mol/kg (i.a.), respectively, ofGRF analogue on different stimuli. We first examined the effect of different doses of VIP in causing a fall in IASP before and after two doses of GRF analogue. GRF analogue caused dose-dependent antagonism of the fall in IASP by VIP (Fig. 10) . (Fig. 1 1) . After 5 ml the fall of IASP in the control was 81.0±2.1% (from 32.6±1.3 to 6.1±0.5 mmHg); this was antagonized to 66.2±8.4% (from 44.1±5.9 to 14.1±3.4 mmHg) and 54.1±2.9% (from 27.5±1.7 to 12.5±1.0 mmHg) after 2.3 X 10-8 and 9.2 X 10-8 mol/kg of GRF analogue, respectively (P < 0.05). As can be seen in Fig. 11 the increasing antagonism to the fall in IASP after balloon distension with higher doses of sponse to the rectoanal reflex in the opossum. This conclusion is supported by the following findings. VIP is a potent relaxant ofIAS smooth muscle. The relaxant effect of VIP is exerted by its action directly at the smooth muscle since the inhibitory response of VIP on the IAS was TTX resistant. The direct inhibitory action of VIP on the IAS smooth muscle strips has also been shown before (1, 3, 21) . However, further support for the conclusion that VIP may act as the inhibitory neurotransmitter in the IAS comes from the present investigation which used selective VIP antagonists: [4CI-D-Phe6,Leu'7] VIP (15) and ( The conclusion of the present investigation is in agreement with that of the LES studies (11, 14) where VIP has been suggested to act as an inhibitory neurotransmitter. Furthermore, a number of studies have shown the presence of VIPcontaining nerve fibers in different regions of the gut (24, 25) and the release of VIP from the venous effluent draining the rectal region in response to pelvic nerve stimulation (9, 10, 13) and rectal distension (9) in cats and pigs. Our studies further suggest that VIP may not be the only neurotransmitter involved in the IAS relaxation by the rectoanal reflex since the VIP antagonists in the doses that almost abolished the fall in IASP caused by lower doses of VIP failed to abolish the IAS relaxation in response to lower levels of neural stimuli. It is possible that another inhibitory neurotransmitter is released in addition to VIP and is partially responsible for IAS relaxation. In that case, it would be important to further examine the role of such a substance in IAS relaxation. Purinergic substances have been shown to act as inhibitory neurotransmitters in a variety of tissues (6) . Our recent studies however rule out the participation of purinergic agents as the inhibitory neurotransmitters in IAS relaxation Furthermore, the antagonists were selective in antagonizing the inhibitory responses of VIP on the IAS without modifying the responses to isoproterenol, adenosine, and PHI. The findings of the present investigation suggest that VIP plays a significant role as an inhibitory neurotransmitter in rectoanal reflex-mediated IAS relaxation. However, further studies seeking electrophysiologic and biochemical correlates for the inhibitory responses of rectoanal reflex, sacral nerve stimulation, local intramural stimulation, and VIP need to be performed. Information relating to the inhibitory neurotransmitter involved in IAS relaxation would lead to a better understanding of the pathophysiology of anorectal incontinence and constipation, as they relate to the reflex control mechanisms of the anorectal region.
